# Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females

> **NCT00745901** · PHASE4 · COMPLETED · sponsor: **Ortho-McNeil Janssen Scientific Affairs, LLC** · enrollment: 355 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Norgestimate/ethinyl estradiol; Drospirenone/ethinyl estradiol

## Key facts

- **NCT ID:** NCT00745901
- **Lead sponsor:** Ortho-McNeil Janssen Scientific Affairs, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 355 (ACTUAL)
- **Last updated:** 2019-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00745901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00745901, "Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00745901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*